Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

F Raffi

Showing results (171-180 of 224) with videos related to

Pageof 23
Sort By:
The Journal of Infection|January 9, 2007
Constant mitochondrial DNA levels in blood leukocytes of patients enrolled in a NRTI-free therapeutic trial (BIKS-2 study)B Amellal, C Allavena, E André-Garnier, et al.
Medecine Et Maladies Infectieuses|June 28, 2011
[Measles in the Nantes Teaching Hospital during the 2008-2009 epidemic]C Biron, O Beaudoux, A Ponge, et al.
International Journal of Bio-Medical Computing|June 1, 1994
Teaching individualized antibiotic dosage regimens by means of two computer-assisted learning programsY Le Normand, H B Drugeon, G Potel, et al.
Medecine Et Maladies Infectieuses|September 4, 2012
Effectiveness and safety of saquinavir/ritonavir in HIV-infected pregnant women: INEMA cohortC Brunet, V Reliquet, T Jovelin, et al.
The Journal of Infectious Diseases|September 1, 1995
Lower survival in AIDS patients receiving dapsone compared with aerosolized pentamidine for secondary prophylaxis of Pneumocystis carinii pneumonia. Study GroupD Salmon-Ceron, A Fontbonne, J Saba, et al.
Antiviral Therapy|March 21, 2000
Stavudine plus didanosine and nevirapine in antiretroviral-naive HIV-infected adults: preliminary safety and efficacy results. VIRGO Study TeamF Raffi, V Reliquet, C Francois, et al.
HIV Medicine|April 25, 2006
Incidence and risk factors of bacterial pneumonia requiring hospitalization in HIV-infected patients started on a protease inhibitor-containing regimenV Le Moing, C Rabaud, V Journot, et al.
Medecine Et Maladies Infectieuses|December 1, 2009
[Contribution of molecular biology and Aspergillus galactomannan antigen assay for the diagnosis of histoplasmosis]S Pineau, J-P Talarmin, F Morio, et al.
Journal of Acquired Immune Deficiency Syndromes (1999)|July 27, 2001
Clinical, biologic, and behavioral predictors of early immunologic and virologic response in HIV-infected patients initiating protease inhibitorsV Le Moing, G Chêne, M P Carrieri, et al.
Clinical and Experimental Immunology|December 14, 2020
Influence of HLA-C environment on the spontaneous clearance of hepatitis C in European HIV-HCV co-infected individualsN Legrand, G David, A Rodallec, et al.
Pageof 23

Showing results (171-180 of 224) with videos related to

Sort By:
Pageof 23
The Journal of Infection|January 9, 2007
Constant mitochondrial DNA levels in blood leukocytes of patients enrolled in a NRTI-free therapeutic trial (BIKS-2 study)B Amellal, C Allavena, E André-Garnier, et al.
Medecine Et Maladies Infectieuses|June 28, 2011
[Measles in the Nantes Teaching Hospital during the 2008-2009 epidemic]C Biron, O Beaudoux, A Ponge, et al.
International Journal of Bio-Medical Computing|June 1, 1994
Teaching individualized antibiotic dosage regimens by means of two computer-assisted learning programsY Le Normand, H B Drugeon, G Potel, et al.
Medecine Et Maladies Infectieuses|September 4, 2012
Effectiveness and safety of saquinavir/ritonavir in HIV-infected pregnant women: INEMA cohortC Brunet, V Reliquet, T Jovelin, et al.
The Journal of Infectious Diseases|September 1, 1995
Lower survival in AIDS patients receiving dapsone compared with aerosolized pentamidine for secondary prophylaxis of Pneumocystis carinii pneumonia. Study GroupD Salmon-Ceron, A Fontbonne, J Saba, et al.
Antiviral Therapy|March 21, 2000
Stavudine plus didanosine and nevirapine in antiretroviral-naive HIV-infected adults: preliminary safety and efficacy results. VIRGO Study TeamF Raffi, V Reliquet, C Francois, et al.
HIV Medicine|April 25, 2006
Incidence and risk factors of bacterial pneumonia requiring hospitalization in HIV-infected patients started on a protease inhibitor-containing regimenV Le Moing, C Rabaud, V Journot, et al.
Medecine Et Maladies Infectieuses|December 1, 2009
[Contribution of molecular biology and Aspergillus galactomannan antigen assay for the diagnosis of histoplasmosis]S Pineau, J-P Talarmin, F Morio, et al.
Journal of Acquired Immune Deficiency Syndromes (1999)|July 27, 2001
Clinical, biologic, and behavioral predictors of early immunologic and virologic response in HIV-infected patients initiating protease inhibitorsV Le Moing, G Chêne, M P Carrieri, et al.
Clinical and Experimental Immunology|December 14, 2020
Influence of HLA-C environment on the spontaneous clearance of hepatitis C in European HIV-HCV co-infected individualsN Legrand, G David, A Rodallec, et al.
Pageof 23